Sarma, A., Kataki, A. C., Rai, A. K., Hazarika, M., Roy, P. S., Kalita, M., … Chattopadhyay, I. (2023). Promoter Hypermethylation of ATG16L2, TFAP2A, EBF2, Calcitonin, ABL1 Kinase Domain T315I Mutation Association with Imatinib Therapy Resistance and Median Survival in CML Patients of North-East India. Asian Pacific Journal of Cancer Care, 8(1), 35–42. https://doi.org/10.31557/apjcc.2023.8.1.35-42